Markets

Stock Market Today: FDA Gives Stocks a Booster Shot

The FDA's emergency-use green light of a COVID-19 treatment helped give the major indices a lift Monday, with the Dow leading the way.

Enthusiasm for potential treatments for COVID-19 continued to boost stocks in this brand-new bull market.

The major indices were helped Monday by an Emergency Use Authorization from the Food and Drug Administration to use antibody-rich plasma from recovered COVID patients to treat serious cases in new patients – despite thin evidence so far of its efficacy.

Financial Times (paywall) also reported on Sunday that "the Trump administration is considering bypassing normal US regulatory standards to fast-track an experimental coronavirus vaccine from the UK for use in America ahead of the presidential election, according to three people briefed on the plan," but AstraZeneca (AZN) denied that report.

The S&P 500 (+1.0% to 3,431) and Nasdaq Composite (+0.6% to 11,379) both set record closing highs, and the small-cap Russell 2000 gained 1% to 1,568. The Dow Jones Industrial Average was the strongest of the major indices, gaining 1.4% to close at 28,308; it remains about 4% below its Feb. 12 all-time closing high.

Looking ahead: Dollar General (DG), Nordstrom (JWN) and Williams-Sonoma (WSM) are among the companies to watch out for in a retail-heavy earnings slate.

The Market's Heavy Tilt Continues

They say a rising tide lifts all boats, but that hasn't been precisely accurate this time around.

Despite Monday's "rotation" day that saw more cyclical sectors take the lead, technology (and tech-related) stocks with mega market values have done most of the lifting in boosting the major indices to record highs, even as many other stocks have delivered dismal returns.

"'Big tech' (how they’re generically compartmentalized) has been a powerful force. Rightly so, the dominance of the five largest stocks in the S&P 500 have received much investor attention (and buying pressure)," writes Liz Ann Sonders, Senior Vice President and Chief Investment Strategist at Charles Schwab, in recent market commentary. "In equal-weighted terms, they represent 1% of the S&P 500; but in cap-weighted terms, they now represent nearly their own quartile."

"That said, it would be in keeping with history for at least some short-term consolidation – which could simply take the form of a rotation away from the concentrated leadership areas vs. something more sinister. Most historical studies of similar periods of concentration show a tendency for flat-to-lower stock prices short-term; but higher prices longer-term."

That shouldn't put longer-term investors off the tried-and-true formula of buying cheap, market-tracking exchange-traded funds, but it's understandable if even generally conservative investors want to be a bit more tactical with their approach. Stock picking is back in fashion because of stark disparities in individual share performance this year. Individual asset classes and market sectors are leaving others behind in the pandemic's new normal.

One way to build a nimble but diversified portfolio aimed at weighting current winners over laggards is to gather up a variety of low-cost ETFs. Read on to discover Kiplinger's 20 favorite cheap ETFs that cover various facets of the market.

Most Popular

Planning to Sell Your Home in Retirement? Downsize Costs Along With Space
Budgeting

Planning to Sell Your Home in Retirement? Downsize Costs Along With Space

In this hot real estate market, consider the costs of buying and selling a house along with the expenses associated with your new digs.
November 13, 2020
What Biden Will Do: 24 Policy Plays to Expect From the Next Administration
Politics

What Biden Will Do: 24 Policy Plays to Expect From the Next Administration

The Kiplinger Letter forecasts President-Elect Joe Biden’s biggest priorities -- and the likelihood of progress on them.
November 19, 2020
The 13 Best Healthcare Stocks to Buy for 2021
Kiplinger's Investing Outlook

The 13 Best Healthcare Stocks to Buy for 2021

Most of the best healthcare stocks for 2021 will have some sort of ties to COVID, whether it's producing a vaccine or cure, or benefiting from the vir…
November 20, 2020

Recommended

Stock Market Today 12/1/20: Wall Street Hangs on Stimulus Hopes Again
stocks

Stock Market Today 12/1/20: Wall Street Hangs on Stimulus Hopes Again

A stimulus package brought by a group of nonpartisan senators Tuesday sparked stocks, which kept most of their gains even after the plan was shot down…
December 1, 2020
Stock Market Today 11/30/20: Dow Closes Out Best Month Since 1987
stocks

Stock Market Today 11/30/20: Dow Closes Out Best Month Since 1987

The major indices dipped Monday despite more positive COVID vaccine news, but the Dow nonetheless capped its best single-month performance in 33 years…
November 30, 2020
25 Stocks That Billionaires Sold in Q3 2020
Investor Psychology

25 Stocks That Billionaires Sold in Q3 2020

Billionaires and high-asset hedge funds dumped a number of holdings during 2020's third quarter. We look at which stocks they've soured on, and why.
November 30, 2020
Stock Market Today 11/27/20: Nasdaq Notches Another High as COVID's Spread Worsens
stocks

Stock Market Today 11/27/20: Nasdaq Notches Another High as COVID's Spread Worsens

An error in AstraZeneca's COVID-19 vaccine trial and persistent coronavirus troubles in the U.S. led investors to chase the old COVID trade Friday.
November 29, 2020